Andrew Dudum sold $6.9M of HIMS
Chief Executive Officer at Hims & Hers Health, Inc.. 333,332 shares at an average of $20.76, traded Nov 5, 2024, filed Nov 7, 2024.
Score components
- +25RoleCEO
- +25Trade size$6.9M at market
- +20Share of holdings soldSold 51% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +44.9%, 3m +71.3%, 6m +117.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001773751-24-000344, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 5, 2024 | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 201510b5-1 | -81,114 | $20.07 | $1.6M | 569,932 | Nov 7, 2024 |
| Nov 5, 2024 | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 201510b5-1 | -50,928 | $21.19 | $1.1M | 519,004 | Nov 7, 2024 |
| Nov 5, 2024 | SOpen-market sale Class A Common Stockindirect: Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 201510b5-1 | -12,402 | $21.76 | $270k | 506,602 | Nov 7, 2024 |
| Nov 5, 2024 | MOption exercise Class A Common Stock10b5-1 | +188,888 | $2.43 | $459k | 255,903 | Nov 7, 2024 |
| Nov 5, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -63,798 | $20.05 | $1.3M | 192,105 | Nov 7, 2024 |
| Nov 5, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -99,987 | $21.19 | $2.1M | 92,118 | Nov 7, 2024 |
| Nov 5, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -25,103 | $21.76 | $546k | 67,015 | Nov 7, 2024 |
| Nov 5, 2024 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -188,888 | $0.00 | $0 | 204,016 | Nov 7, 2024 |
Related signals
Other insiders at Hims & Hers Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $101k 3,461 shares | -1% | |
| 17Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $59k 2,000 shares | -1% | |
| 30Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $877k 29,277 shares | -11% | |
| 32Weak | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $355k 12,313 shares | -5% | |
| 21Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $174k 6,236 shares | -2% | |
| 31Weak | Hims & Hers Health, Inc. | Michael Chi Chief Operating Officer | $398k 14,027 shares | -3% | |
| 23Weak | Hims & Hers Health, Inc. | Mohamed Elshenawy CTO | $226k 7,954 shares | -4% | |
| 20Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $98k 3,458 shares | -1% | |
| 21Weak | Hims & Hers Health, Inc. | Soleil Boughton Chief Legal Officer | $155k 2,637 shares | -2% | |
| 47Moderate | Hims & Hers Health, Inc. | Oluyemi Okupe Chief Financial Officer | $5.1M 85,000 shares | -55% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.